Abstract:Abstract The understanding of the role of intestinal bacteria in various intestinal diseases has been limited due to the lack of suitable in vitro models. However, recent advancements in Gut-on-a-Chip culture technology provide a promising avenue for exploring complex interactions between intestinal epithelium and bacteria. In this study, we aimed to create a microfluidic Gut-on-a-Chip co-culture system using dogs as a model. Dogs share similarities with humans in terms of intestinal disease pathophysiology, clinical presentations, and intestinal microbiome, making them a relevant model for various intestinal diseases, including inflammatory bowel disease (IBD). We cultured colonoids from both healthy dogs and dogs with IBD on the Gut-on-a-Chip platform to create villus-like structures under dynamic conditions. Co-cultures with non-pathogenic Escherichia coli (NPE) were established in the Gut-on-a-Chip with healthy colonoids, and we conducted a static Transwell (TW) co-culture for comparison. To assess epithelial barrier integrity, we measured transepithelial electrical resistance (TEER), and we evaluated the expression of ZO-1, a tight junction protein, through immunofluorescence staining (IF). Following 6-9 days of uninterrupted medium flow in the Gut-on-a-Chip models, we observed sporadic clusters of villus-like structures (i.e., 3D morphogenesis) in canine intestinal epithelial cells in both the models derived from healthy dogs and those with IBD. The IF confirmed the presence of ZO-1, indicating the establishment of tight junctions. Infection with NPE in the TW system resulted in a significant reduction in TEER (48.2±4.4% at 12 hours and 7.3±5.3% at 24 hours). In contrast, the Gut-on-a-Chip maintained TEER levels at 100.3±12.8% at 12 hours, 94.9±2.2% at 24 hours, and 88.8±15.0% at 48 hours, preserving the 3D structure. The innovative canine Gut-on-a-Chip model, capable of reproducing villus-like structures and preserving a 3D configuration using both healthy and diseased organoids (specifically, IBD), presents a valuable platform for investigating bacterial-epithelium interactions in both human and veterinary medicine. This dynamic microfluidic culture system enables the co-cultivation of living bacteria while maintaining epithelial integrity, facilitating the study of intricate interactions between intestinal bacteria and epithelial crosstalk.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a personalized human Paneth cell model using intestinal organoid technology. Specifically, the goal of the study is to specifically enrich the Paneth cell population through intestinal organoids (HIOs) generated from induced pluripotent stem cells (iPSCs). Paneth cells are a specialized subtype of intestinal epithelial cells, and their main function is to produce antimicrobial peptides (AMPs). Changes in Paneth cell function are associated with Crohn's disease (CD), but it is difficult to determine the causes of these changes due to the influence of environmental factors and/or genetic variations. Therefore, through this model, researchers hope to better understand how environmental factors and genetic variations affect the function of human Paneth cells, thereby providing a new approach for personalized research on Crohn's disease. ### Research Methods 1. **Source of iPSCs**: Induced pluripotent stem cells (iPSCs) were obtained from one healthy control individual and two Crohn's disease patients. 2. **Generation of HIOs**: iPSCs were directionally differentiated into intestinal organoids (HIOs), and then dissociated to generate purified epithelial cell organoids (eHIOs). 3. **Enrichment of Paneth Cells**: eHIOs were passaged once a week in a proliferation medium, and the γ - secretase inhibitor DAPT was added to guide the cells to differentiate towards the Paneth cell fate. 4. **Detection Methods**: - **Flow Cytometry**: Detect the expression of the Paneth cell marker lysozyme. - **Quantitative PCR (qPCR)**: Detect the expression of Paneth cell - related genes (such as DEFA5, DEFA6, ITLN2, REG3A and PLA2G2A). - **Immunocytochemistry**: Detect the expression of lysozyme granules and other antimicrobial peptides (such as DEFA5, ITLN2 and REG3A). - **Bacterial Sensor Detection**: Detect the expression of bacterial sensors (TLR2, TLR5 and NOD2) in Paneth cells. ### Research Results 1. **Control Group**: eHIOs derived from iPSCs generated from healthy control individuals could maintain a proliferative state for at least 4 months. Flow cytometry analysis showed that after DAPT treatment, the proportion of Paneth cells increased significantly from approximately 1% to approximately 28%. qPCR analysis indicated that DAPT treatment significantly increased the expression of DEFA5, DEFA6, ITLN2, REG3A and PLA2G2A genes. Immunocytochemistry showed that cells containing lysozyme granules and other antimicrobial peptides were enriched in eHIOs after DAPT treatment. 2. **Crohn's Disease Patient Group**: Applying the same enrichment protocol, the proportion of Paneth cells in eHIOs of Crohn's disease patients increased significantly from approximately 1% to approximately 10%, and the expression of Paneth cell - related genes in these cells also increased significantly, and cells containing lysozyme granules and other antimicrobial peptides were also enriched. ### Conclusion Researchers have successfully developed a method to enrich Paneth cells in iPSC - derived intestinal organoids generated from healthy individuals and Crohn's disease patients. Since iPSCs can be obtained from known biobanks or generated from a small blood sample of Crohn's disease patients, this model system provides a new approach for studying how environmental factors (microorganisms/cytokines) and/or genetic variations affect human Paneth cell function. This will help to gain a deeper understanding of the pathogenesis of Crohn's disease and provide new ideas for personalized treatment.

3D MORPHOGENESIS AND BACTERIAL CO-CULTURE IN A CANINE GUT-ON-A-CHIP USING BIOPSY-DERIVED INTESTINAL ORGANOIDS FROM HEALTHY AND IBD PATIENTS

Establishment of a Gut-on-a-chip Device with Controllable Oxygen Gradients to Study the Contribution of Bifidobacterium Bifidum to Inflammatory Bowel Disease.

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip

A Versatile Intestine‐on‐Chip System for Deciphering the Immunopathogenesis of Inflammatory Bowel Disease

P037 Modelling gut complexity and disease: development of a next-generation adult stem cell based tubular gut-on-a-chip model

Contributions of the microbiome to intestinal inflammation in a gut-on-a-chip

Primary exploration of host–microorganism interaction and enteritis treatment with an embedded membrane microfluidic chip of the human intestinal–vascular microsystem

Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease

Intestinal organ chips for disease modelling and personalized medicine

Recapitulation of the accessible interface of biopsy-derived canine intestinal organoids to study epithelial-luminal interactions

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality.

3D in vitro morphogenesis of human intestinal epithelium in a gut-on-a-chip or a hybrid chip with a cell culture insert

Immunocompetent Intestine-on-Chip Model for Analyzing Gut Mucosal Immune Responses

A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies

Gut-on-a-chip for disease models

Intestine‐on‐a‐chip for Intestinal Disease Study and Pharmacological Research

Developing an advanced gut on chip model enabling the study of epithelial cell/fibroblast interactions

Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling

Advances in reconstructing intestinal functionalities in vitro: From two/three dimensional-cell culture platforms to human intestine-on-a-chip

Immunoresponsive microbiota-gut-on-chip reproduces barrier dysfunction, stromal reshaping and probiotics translocation under inflammation